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ABSTRACT 
 
Natural products or traditional medicine has been used for centuries to treat various ailments by 
mankind. The World Health Organization estimates that in recent times 80% of people in 
emerging economies rely on traditional medicine as their primary health care [1]. However, 
unlike pharmaceutical products which have methods in place for quantification of the active 
compounds traditional medicine still requires a lot of focus in this area. Moringa oleifera is one 
of those species that have been used traditionally to cure various ailments for centuries. Even 
though extensive phytochemical and pharmacological studies have been conducted on the 
different parts of the plant, there is still no analytical method that enables the quantification of 
the compounds in the Moringa products in the market. The aim of this research was to develop 
an HPLC separation method that can be used to quantify the compounds found in the Moringa 
oleifera products. 
Compounds were extracted from the seeds of Moringa oleifera using the maceration method 
with a mixture of water and ethanol (1:1 v/v). The compounds were isolated using preparative 
HPLC. The structures of the compounds were elucidated using FTIR, NMR and MS. An HPLC 
separation method for quantification of the isolated compounds was developed and validated. 
The method was applied to the crude extract to quantify the isolated compounds in the extract. 
The following compounds 3-caffeoylquinic acid, 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate, 
O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate and O-butyl-[4-(α-L-Rhamnosyloxy) 
benzyl] thiocarbamate were isolated at percentage purities ranging from 90 to 99%. The HPLC 
separation method for quantification showed a linear relationship between peak area and 
 vii 
 
concentration of the compounds with regression coefficients ranging from 0.9977 to 0.9994. The 
method is also precise with % RSD values between 0.01 and 1.16%. The method was shown to 
be specific to the compounds of interest. The percentage distribution of compounds in 50 mg of 
the seeds extract was between 0.25 and 1.10 % w/w. 
This study successfully developed and validated an HPLC separation method for four 
compounds found in the seeds of Moringa oleifera and quantified them in the crude extract of 
the seeds found in Zambia. This method can be used for identification and quantification of these 
four compounds in any of the Moringa products. As far as it could be ascertained this is the first 
time that such a method has been developed for these compounds. 
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CHAPTER ONE 
1.1 Background 
 
For centuries mankind has relied on the use of traditional medicine to cure various ailments.  The 
most popular include African, Arabic, Chinese and Indian traditional medicine [1].  Natural 
products from plants have been and continue to be vital to mankind as a source of nutrition, for 
beauty treatment and medicine [2].  The World Health Organization estimates that 80% of 
people in emerging economies rely on traditional medicine as their primary health care [3].  This 
is mainly because of the lack of good health care facilities and the high cost of western medicine 
whereas traditional medicine is accessible and affordable.  This is the case in South Africa where 
the Conserve Africa Foundation has reported that the ratio of traditional practitioners to patient is 
1: 700-1200 and that of western doctors to patient is 1: 17 400 [4,5].   
Natural products are described as pharmacologically and biologically active secondary 
metabolites found in nature or compounds produced by living organisms as a defence 
mechanism against microbial attack, animal predation and ultraviolet radiation [6,7].  These 
metabolites include groups of compounds such as alkaloids, terpenoids and phenolics.    Table 
1.1 shows some of the compounds derived from natural products and their uses. 
 
 
 
 
 2 
 
Table 1.1 Chemicals derived from natural products and their uses [8, 9] 
Chemical Scientific 
Source name 
Clinical use Traditional use Traditional 
Source name 
Atropine Atropa 
belladonna 
Anticholinergic headache, 
inflammation, 
menstrual 
symptoms 
Deadly 
nightshade 
Caffeine Camellia 
sinesis 
Central nervous 
system stimulant 
Tonic, stomach 
disorder, diarrhoea 
Tea plant 
Cocaine Erythroxylum 
cola 
Local 
anaesthetic 
Suppress pain, 
hunger, thirst 
Cocoa 
Danthron Cassia species Laxative Used to treat 
various infections 
Golden shower 
tree 
L- Dopa Mucuna species Anti- 
parkinsonism 
Snakebite, 
diarrhoea. 
Velvet bean 
 
Morphine Papaver 
somniferum 
Analgesic To induce sleep, 
headache. 
N/A 
Penicillin Penicillium 
fungi 
Antibacterial N/A N/A 
Quinine Cinchona 
ledgeriana 
Antimalarial/ 
antipyretic 
Loss of appetite N/A 
Galantamine 
hydrobromide 
Galanthus 
nivalis 
 Alzheimer’s 
disease 
Neurological 
conditions 
Snowdrop 
Artemotil Artemisia 
annua 
Antimalarial To cure chills and 
fever 
Sweet annie, 
Wormwood 
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1.2 Studies on traditional African medicinal plants 
 
Traditional medicine was recognised as the source of primary health care in the Primary Health 
Care Declaration of Alma Ata 1978 [3].  That coupled with the developments in analytical 
techniques, development of drug-resistant micro-organisms, side effects caused by modern drugs 
and emerging diseases has led to renewed attention in traditional medicine so as to provide novel 
chemical entities [10].  There are ongoing phytochemical and pharmacological studies on 
African medicinal plants.  These studies involve testing the crude extract for biological activities 
followed by isolating and characterizing the active compounds.  Ongoing studies include those 
on plants such as the kola plant originally found in West African countries.  The species Cola 
acuminate is used traditionally as an antidote for poisoning, to suppress appetite, increase 
alertness and to treat migraines as well as motion sickness [11]. 
The Cajanue cajan, also called pigeon pea, is found in Senegal, East Africa and South Africa.  It 
is traditionally used as a painkiller, to treat skin irritation, measles and jaundice [12].  The 
following compounds found in the plant; hexadecanoic acid, α-amyrin, β-sitosterol, pinostrobin, 
lonistylin A and C have been found to possess anti-cancer properties.  Another compound, 
cajanuslacton, isolated by Kong Y et al from the plant has anti-bacterial activity [13].  Hoodia 
gordonii is a leafless thorny plant that grows naturally in South Africa and Namibia.  It has long 
been used to treat indigestion and mild infections.  The compound P57, a glycoside with the 
molecular formula C47H74O15 responsible for the appetite-suppressant effect, was isolated from 
the plant by the South African Council of Scientific and Industrial Research (CSIR) in 1977 [14].    
Moringa is found in different communities across Africa, Asia and the Caribbean. The plant is 
used traditionally to cure ailments such as ulcer, digestive problems, fungal infections and for 
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wound healing [15]. Moringa contains compounds such as niazimicin that is reported to have 
anti-tumor activity [16]; benzyl isothiocyanate and benzyl glucosinolate were found to have anti-
fungal and anti-bacterial activities [17]. The phytochemistry for most of these plants is complete; 
however there are no analytical methods in place to enable the quality control and quality 
assurance of the products made from them. This study focuses on Moringa oleifera which is one 
of the species of Moringa. 
 
1.2 Motivation for study 
 
There is continued interest in the Moringa plant because of its many uses especially the 
medicinal uses such as the treatment of urinary tract infections, diabetes and many more [18, 19].  
Extensive phytochemical and pharmacological studies have been conducted on the different parts 
of the plant such as the leaves, seeds, bark and roots.  However, there are no methods in place to 
determine the distribution of the compounds within the plant or the quantity of the compounds in 
the Moringa products in the market such as those shown in Figure 1.1.  The challenge or 
limitation in developing quantification methods is the lack of commercial reference standards for 
the compounds found in the Moringa plant.  Therefore, this study focuses on generating 
reference standards, developing and validating an HPLC separation method for quantification of 
the compounds found in the Moringa oleifera plant.  The validated method will provide the 
platform for the quality control of the Moringa oleifera products in the market. 
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Figure 1.1 Moringa oleifera products in the South African market [20,21] 
 
1.4 Aims and objectives 
 
The aim of this study is to develop a quality control method for the Moringa oleifera plant.  For 
this study, Moringa oleifera seeds were used. 
1.4.1 Specific objectives 
 
 To isolate and characterize the constituents of the seeds of Moringa oleifera; 
 To develop and validate an HPLC separation method for the isolated compounds; 
 To quantify the isolated compounds in the crude extract of the seeds of M. Oleifera. 
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CHAPTER TWO 
 
2.1 Introduction to Moringa 
 
Moringa is a medicinal plant that is the sole genus from the flowering plant family Moringaceae.  
The Moringaceae family is identified by its parietal placentation, 3-valved fruit, elongated, non-
dehiscent berry and winged seeds [22].  Moringa is native to African and Asian countries and it 
is being cultivated in different parts of the world including South Africa because of its many uses 
[23].  It has thirteen species with Moringa oleifera being the most cultivated followed by 
Moringa stenopetalla [15].  The species are divided into three categories; bottle trees, slender 
trees and tuberous shrubs (see Table 2.1). 
 
The species of interest in this study is Moringa oleifera, commonly called the drumstick tree, 
horseradish tree, Mupulanga in Zimbabwe, Haleko in Ethiopia [24].  The plant is a fast growing, 
small, hard tree producing tuberous taproot.  It has a straight trunk, whitish bark, green leaves 
about 1 to 2 cm long and white coloured flowers that are 10 to 25 cm long.  The pods are green 
or reddish in colour and the seeds are round, white with a brown cover see Figure 2.1.  The plant 
grows in tropical and sub-tropical areas, thriving well in well-drained soil at a neutral pH.  The 
Moringa oleifera plant can grow up to 12 m tall [25].  
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Table 2.1  The different species of Moringa [26, 15] 
Species Country of origin Morphology 
Moringa  arborea Kenya Tuberous shrub 
Moringa borziana Kenya, Somalia Tuberous shrub 
Moringa concanensis India, Pakistan Slender tree 
Moringa drouhardii Madagascar Bottle tree 
Moringa hildebrandtii Madagascar Bottle tree 
Moringa longituba Ethiopia, Kenya, Somalia Tuberous shrub 
Moringa oleifera India Slender tree 
Moringa ovalifolia Angola, Namibia Bottle tree 
Moringa peregrina Ethiopia, Eritrea, Djibouti, Israel, 
Jordan, Somalia, Sudan, Syria, 
Yemen, Iran, Pakistan 
Slender tree 
Moringa pygmaea Somalia Tuberous shrub 
Moringa  rivae Ethiopia, Kenya Tuberous shrub 
Moringa ruspoliana Ethiopia, Kenya, Somalia Tuberous shrub 
Moringa stenopetalla Ethiopia, Kenya, Somalia Bottle tree 
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Figure 2.1 (a) Moringa oleifera tree [27] (b) Moringa oleifera pods [28] (c & d) 
Moringa oleifera seeds 
 
2.2  Uses of Moringa 
 
The use of Moringa as a medicinal plant dates back to ancient times.  Evidence of the 
usage of the plant (by the Egyptians, Greeks, Indians and Romans) can be found from 
ancient writings dating back to 150 B.C. [29].  Moringa is often referred to as the ‘magic 
bullet’ or the ‘miracle tree’ because of its many uses, some of which have been proven 
scientifically.  Every part of the plant is reported to have some use either nutritional, 
medicinal, environmental, and cosmetic use or all of them (Figure 2.2) [15].  Moringa is 
being used traditionally to treat various ailments such as anxiety, asthma, chest 
b a b 
c d 
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congestion, cholera, cough, diabetes, diarrhoea, ear infections, fever, joint pains, scurvy, 
semen deficiency, skin infections, sore throat, tuberculosis, venous bites and more as 
summarized in Figure 2.3 [30, 15].  The knowledge on how to use Moringa to treat the 
mentioned ailments has been passed down from generation to generation.  
 
Moringa oleifera has exhibited nutritional, therapeutic and prophylactic properties [16].  Studies 
of extracts from different parts of the plant have been found to have anti-inflammation, 
anticancer, antimalarial, antidiuretic, antispasmodic, antimicrobial properties etcetera [31, 32].  
The leaves, flowers and green pods are eaten as vegetable and they are also used for the 
treatment of malnutrition in children and breast feeding mothers [30].  The seeds have proven 
effective for purification of water in areas where clean water is scarce [17].  The seed oil is used 
for cooking and for cosmetic purposes. 
 
Figure 2.2  Uses of the different parts of Moringa tree [33] 
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Figure 2.3  Traditional medicinal uses of Moringa [34] 
 
2.2.1  Moringa oleifera in water treatment 
 
The usefulness of Moringa oleifera seeds in water treatment has been shown in several studies.  
Moringa oleifera seeds yield a natural cationic polypeptide which is soluble in water.  This 
positively charged protein acts as a coagulant by binding with the negatively charged particulate 
matter, reducing the water turbidity, the total water hardness, acidity and chloride content [24, 
17].  A study using the two-stage clarifier tanks with the arrangement of natural filter media, 
coconut fiber, followed by sand media combined with powdered Moringa oleifera seeds as 
natural coagulant, resulted in significant improvement of the quality and appearance of tapioca 
starch waste water final effluent [35].  The water pH, biochemical oxygen demand, total 
suspended solids and total solids were also stabilized.  
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In another study Moringa oleifera seeds were found to remove up to 95% of the total bacteria in 
water.  The bioactive steroidal glycoside-strophantidin isolated from the seeds is responsible for 
the activity.  Steroidal glycoside-strophantidin is also responsible for the clarification and 
sedimentation of inorganic and organic matter in raw water [36].  Mangale S.M et al [17]  
identified the compounds benzyl isothiocyanate and benzyl glucosinolate to be responsible for 
the activity against bacteria and fungi in water.  In their study, Ndabigengesere A. et al [37] 
recommended that Moringa oleifera seeds can be used to replace or as an alternative to alum for 
water treatment because they do not result in corrosion problems. 
 
2.3  Scientific analysis of medicinal plants 
 
Studies on medicinal plants follow the framework shown below in Figure 2.4.  A crude extract is 
obtained from the plant and can be screened for biological activities.  This is followed by 
separation and isolation of individual compounds from the extract.  Finally the structures of the 
compounds are elucidated using spectroscopic techniques.  
2.3.1 Extraction techniques for medicinal plants 
 
Extraction of secondary metabolites from plant material is the most important sample preparation 
step in the analysis of medicinal plants [38, 39].  The extraction step involves the separation of 
secondary metabolites from the matrix.  This is achieved by using solvents which the secondary 
metabolites are soluble in, whilst excluding most of the other components in the plant.  There are 
several methods that have been developed and are used for the extraction of metabolites.  First 
there are the traditional or conventional methods which include; Soxhlet extraction, maceration 
 12 
 
and sonification.  The modern techniques are supercritical fluid extraction, microwave assisted 
solvent extraction etcetera.  Overall an ideal extraction method should be fast, simple and 
inexpensive.  It should give high yields of the compounds of interest without loss or degradation 
and should have little or no solvent waste disposed into the environment [
38,40
]. 
 
The choice of solvent for extraction depends on the compounds of interest.  The compound/s of 
interest should be highly soluble in the solvent.  For example if the interest is in extracting non-
polar compounds like oils, a non-polar solvent such as hexane is used as an extracting solvent.  
Whereas for polar compounds, a polar solvent (ethanol) is used for extraction [41].  The boiling 
point of the solvent is also a very important parameter to consider because the extract has to be 
concentrated by evaporating the solvent and hence the boiling point of the solvent should not be 
too high to avoid degradation of the extracted compounds.  Additionally the extracting solvent 
should not react chemically with the extract resulting in different compounds being formed.  The 
solvent should also be inexpensive, safe to use, environmentally friendly and suitable for reuse 
[42].  
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Figure 2.4  Framework followed for the analysis of medicinal plants, where LPCC= Low 
pressure liquid chromatography, HSCC= High speed counter current, HPLC= 
High pressure liquid chromatography and FCC= Flash column chromatography. 
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2.3.1.1 Traditional methods of extraction 
 
 Maceration 
 
This method uses an organic solvent such as methanol or a mixture of an organic solvent and 
water as an extracting solvent.  Extraction is performed at room temperature with occasional 
stirring or shaking of the mixture.  The amount of solvent that is used depends on the sample size 
and it is usually a ratio of 1:5 (sample: solvent).  The time required for extraction is 3- 4 days.  
With this method repeated extraction yields better results [41].  
 Soxhlet extraction 
 
Soxhlet extraction uses an organic solvent or a mixture of water and an organic solvent for 
extraction.  The solvent is heated to its boiling point and extraction of the metabolites from the 
sample takes place after the solvent has condensed. The method uses 100-200 mL of the solvent.  
Extraction usually takes between 3-18 hours [38, 41].  
 Sonication 
 
Sonification uses the same solvents as the two methods described above.  Moderate heat is 
applied to the system and extraction requires about 50-100 mL of the extracting solvent.  The 
extraction time can be as long as about an hour [41].  
The advantage and disadvantages of these methods are given in Table 2.2. Even though these 
methods are simple and easy to use, they however, require large amounts of the solvent. The 
extraction time for maceration and soxhlet extractions is long. 
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Table 2.2 Advantages and disadvantages of traditional or conventional methods of 
extraction [43, 39]. 
Extraction 
method 
Advantages  Disadvantages 
Maceration  Simple and easy to use 
 Economical in terms of 
glassware 
 A large amount of the solvent is used 
 It is time consuming due to long 
extraction time 
 It is not selective to the analyte 
Soxhlet 
extraction 
 The sample is repeatedly 
brought into contact with fresh 
solvent 
 No filtration is required after 
extraction 
 Several extractions can be set 
up simultaneously because the 
glassware is not expensive 
 High solvent consumption 
 Long extraction time 
  Increased temperature may lead to 
degradation of compounds 
Sonification  Less solvent consumption 
 Shorter extraction time 
 May lead to degradation of the 
analytes 
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2.3.1.2  Modern methods of extraction 
 
 Supercritical fluid extraction 
 
Compounds of interest are separated from the matrix using supercritical fluid as the extracting 
solvent. When the fluid is between the gaseous and liquid state (its critical point), temperature 
and pressure are manipulated so that it can solubilize the compounds of interest and extract them.  
Carbon dioxide is used as the extracting solvent because it has near ambient critical temperature 
of 31
º
C, which avoids degradation of the compounds.  Carbon dioxide is sometimes modified by 
ethanol or methanol to increase its polarity as the extracting solvent [38]. 
 
 Microwave assisted solvent extraction 
 
The solvent is added to the sample and heated with microwave energy.  The heating results in the 
rupture of the cell wall of the plant sample followed by the release of the compounds to the 
solvent.  This technique is a combination of closed-vessel microwave acid digestion and solvent 
extraction of metabolites from the solid sample [
44
]. 
 
There are advantages and disadvantages associated with these methods and they are given in 
Table 2.3. Unlike the traditional methods of extraction, these methods are quick and only use 
small amounts of the solvent. 
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Table 2. 3  Advantages and disadvantages of modern extraction methods [45–47] 
Extraction method Advantages Disadvantages 
Supercritical fluid 
extraction 
 Environmentally friendly 
 Extraction is done at low 
temperatures which 
avoids degradation of the 
metabolite 
 Carbon dioxide (CO2) is 
inert and nonflammable 
 
 There is loss of the analyte 
during collection of the 
extracted analytes 
 Carbon dioxide used as the 
extracting solvent has 
limitations with regards to 
polarity 
Microwave assisted 
solvent extraction 
 Short extraction time 
 Reduced solvent 
consumption 
 The method is 
reproducibility 
 Degradation of the 
compounds because of high 
temperature 
 A decrease in extraction 
yields because of 
overexposure to microwave 
radiation 
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The modern extraction techniques offer more and better advantages than the traditional methods 
with respect to green chemistry (Tables 2.2 and 2.3).  However, most institutions and 
laboratories do not have the instruments required for these methods because of their high cost.  
Hence, most extractions are still carried out using traditional methods like maceration which is 
popular because it is convenient, simple and easy to use.  Vongsak et al. [40] suggested that 
maceration is more applicable to small and medium enterprises and emerging economies because 
of the above-mentioned reasons.  Several laboratory researchers have investigated the efficiency 
of different extraction methods by comparing their extraction yields.  Bampouli et al. [
48
] 
determined the extraction efficiencies of ultrasound assisted extraction (UAE) (a modern 
extraction method), Soxhlet extraction (SE), microwave assisted extraction (MAE) and 
supercritical fluid extraction (SFE) on the leaves of Pistacia lentiscus var. chia by comparing 
their extraction yields and antioxidant activity of the extracts.  MAE was found to have the 
highest extraction yield and antioxidant activity followed by UAE then SE.  SFE had the least 
extraction yield and the extract had no antioxidant activity [
48
]. 
 
Maceration and Soxhlet extractions were compared for their extraction efficiency on Bacopa 
monnieri using different solvents.  The highest extraction yield was found from maceration using 
methanol [
49
].  Extraction from the leaves of Mentha spicata using the Soxhlet technique resulted 
in higher crude extract yield as compared to supercritical fluid extraction.  However, upon 
quantification using HPLC the SFE extract was found to have more flavonoid compounds than 
that of the Soxhlet extract [
50
].  This was attributed to SFE being selective to a group of 
compounds.  Maceration gave maximum amounts of total phenolics and total flavonoids when it 
was compared to squeezing, percolation (both traditional methods) and Soxhlet extraction. 
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Hence, maceration was recommended as the method of choice because it is simple, convenient 
and economical [40].  Based on these various reports, it can be suggested that the choice of 
extraction method should be based on the objective of the study. That is, whether a high 
extraction yield is required or specific group of compounds are targeted.  
 
2.3.2  Separation of compounds using chromatography 
 
The crude extract contains a mixture of different types of secondary metabolites or 
phytochemicals.  To be able to identify and characterize these phytochemicals, they first have to 
be separated and purified [41].  Chromatography is a powerful technique used for separation and 
purification of compounds.  There are different chromatographic techniques that can be used for 
the isolation of phytochemicals from a crude extract (see Table 2.4).  The chromatographic 
system consists of a stationary phase and a mobile phase.  The analytes are transported through 
the stationary phase by the mobile phase and separation of the analytes within the sample is 
based on their different affinities for the mobile or stationary phase [2].  For separation and 
isolation of secondary metabolites from natural products, preparative chromatography is used 
which enables separation and collection of large quantities of the compounds ranging from 
milligrams to grams [42]. 
 
  
 20 
 
2.3.2.1  Thin layer Chromatography (TLC) 
 
TLC is a quick, easy and cheap method for the separation of compounds in a mixture.  It is 
mostly used to check the number of compounds in a mixture and to assess the purity of a 
compound.  It can also be used to confirm the identity of a compound that is present in a mixture 
by comparing the retardation factor (Rf) of the compound in question with that of the reference 
standard.  The separation is based on adsorption, partition or both depending on the adsorbent 
used.  The adsorbent which is the stationary phase is a thin layer of silica applied to a support 
such as glass, aluminium or plastic plate.  The mobile phase is the solvent used to transport the 
compounds through the stationary phase by capillary action.  Separation occurs as the 
compounds travelling through the stationary phase are adsorbed and released at different rates, 
depending on their affinity for the stationary phase [
51
, 
52
]. 
 
Thin Layer Chromatography is one of the oldest separation techniques with several advantages 
that include: 
 It is cheap and simple to use 
 It requires less time for separation 
 It is sensitive 
 It is able to separate several samples simultaneously 
 The method can be up-scaled to column separation 
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2.3.2.2 Column chromatography 
 
Separation in column chromatography (CC) is also based on adsorption and partition similar to 
TLC.  However in CC the stationary phase is packed in a column and the mobile phase moves 
down the column due to gravity or external pressure.  Modifying the process of CC by applying 
external pressure results in a technique called Flash Column Chromatography (FCC).  Flash 
column chromatography uses a pump to generate pressure higher than the gravitational pressure, 
but lower than the high pressure used in high pressure liquid chromatography (HPLC).  FCC 
results in the reduction of time for separation of compounds from hours in normal column 
chromatography to minutes.  This method allows separation, isolation and purification of large 
quantities of the compounds, if required for further studies such as identification and 
characterization of the compound as well as pharmacological studies [
53
]. 
 
2.3.2.3  High Performance Liquid Chromatography 
 
This is a separation technique similar to CC and FCC, which uses very small particle size 
packing (3 µm, 5 µm and 10 µm) for the stationary phase.  The smaller particle size packings 
lead to very high back pressure and hence the need for high pressure for the mobile phase.  The 
separation is based on the adsorption, partition, ion exchange and size exclusion or gel 
permeation stationary phase.  The separation of the components of a mixture is achieved due to 
difference of the component’s affinity for the stationary phase.  The advantages of this method 
are that it is quick, efficient, automated, highly accurate and reproducible [41].  Separation of 
most phytochemicals can be accomplished using isocratic mode where the mobile phase 
composition is kept constant throughout the separation.  However, gradient elution is used to 
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separate compounds that do not separate well under isocratic conditions and have long separation 
time [41].  Several detectors that have been used with HPLC which include; diode array (DAD), 
fixed or variable Ultraviolet/visible (UV-VIS), fluorescence (FLD), mass spectrometer (MS), 
refractive index (RID), and electrochemical light scattering (ELSD) detectors.  The most 
commonly used in this work is the diode array detector [
52
].  When performing quantitative and 
qualitative work on the HPLC, reference standards are required except when the aim is to 
separate and purify the compounds in a mixture. 
 
 
 
2.4  Phytochemical studies done on Moringa oleifera 
 
Phytochemical studies are conducted to discover bioactive secondary metabolites, which may be 
used to treat diseases [59, 60].  These studies have gained popularity in recent years to 
investigate natural compounds that can be used as an alternative to synthetic drugs which are 
associated with adverse side effects [
56
].  Extensive phytochemical studies have been conducted 
on the seeds of Moringa oleifera. Thirty compounds that have been identified from the seeds of 
the plant in different areas are shown in Table 2.5 and their structures in section 2.8.1.  Guevara 
A.P et al [16] isolated eight compounds, seven of which were already known.  The compounds 
were isolated using flash column chromatography (FCC), and preparative HPLC was used for 
purification of the isolated compounds.  The purity of the compounds was assessed using TLC.  
The structures of the compounds were elucidated using MS, IR, 
1
H and 
13
C NMR. 
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A new compound in the Moringa species 4-(β-D-glucopyranosyl-1-4-α-L-rhamnopyranosyloxy)-
benzylthiocarboxamide was isolated together with known compounds 4-(α-L-
rhamnopyranosyloxy) benzyl isothiocyanate and methyl-N-4(α-L-rhamnopyranosyloxy) benzyl 
carbamate using preparative HPLC [
57
].  Characterization of the compounds was carried out 
using ultraviolet/visible spectrometry, infrared spectrometry, mass spectrometry and NMR.  
Oleic, palmitic and behenic acids, β-sitosterol, stigmasterol, campesterol, α- and ϒ-, tocopherols 
were identified in Moringa oleifera seeds using gas chromatography-mass spectrometer [
58
].  
Liquid chromatography-mass spectrometry was used for the detection and identification of 4-(α-
L-rhamnopyranosylosy)-benzyl glucosinolate in the seeds [31].  4(α-L-rhamnosyloxy) phenyl 
acetonitrile, stigmasterol, β-sitosterol, 4-(4’-O- acetyl-α-L-rhamnosyloxy) benzyl isothiocyanate, 
4-(α-L-rhamnosyloxy) benzyl isothiocyanate, squalene and sitosterol were isolated using column 
chromatography and preparative HPLC.  The compounds were characterized using FTIR, MS, 
NMR and UV-VIS. [64, 65]. 
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Table 2.4 Some of the compounds isolated from Moringa oleifera seeds 
Phytochemicals Extracting 
solvent 
Reference 
1. O-ethyl-4(α-L-rhamnosyloxy) benzyl 
carbamate 
2. 4-(α-L-rhamnosyloxy) benzyl 
isothiocyanate 
3. O-ethyl-4(α-L-rhamnosyloxy) benzyl 
carbamate  
4. β- sitosterol 
5. Glycerol-1-(9-octadecanoate) 
6. 3-O-(6’-O-oleoyl-β-D-glucopyranosyl)-
β-sitosterol 
7. β-sitosterol-3-O-β-D-glucopyranoside 
Ethanol [16] 
8. 4-(α-L-rhamnosyloxy) benzyl 
glucosinolate 
Methanol [31] 
9. Moringyne 
10. Mono-palmitoc 
Ethanol [
61
] 
11. Di-oleic triglyceride  [
62
] 
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Table 2.4  …..continued 
12. Oleic acid 
13. Palmitic acid 
14. Stearic acid 
15. Behenic acid 
16. Arachidic acid 
 [
63
] 
17. 4(α-L-rhamnosylosy) phenylacetonitrile Water or ethanol [64, 16] 
18. 4-(β-D-glucopyranosyl-1-4-α-L-
rhamnopyranosyloxy)-
benzylthiocarboxamide 
 [
57
] 
19. Gallic acid 
20.  Quercetin 
Methanol [
65
] 
21. Chlorogenic acid 
22. Ferullic acid 
23. Kaempferol 
24. Vanillin 
Water 
66
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2.8.1  The structures for some of the isolated compounds are shown below  
 
 
 
 
 
 
Compound name R Reference 
4-(α-L-rhamnosyloxy) benzyl 
isothiocyanate  
N C S 
[16] 
O-ethyl-4(α-L-rhamnosyloxy) 
benzyl carbamate 
H
N C O CH2 CH3
O
 
[16] 
O-ethyl-4(α-L-rhamnosyloxy) 
benzyl thiocarbamate  
[16] 
4-(α-L-rhamnosylosy) benzyl 
glucosinolate 
 
[31] 
4-(α-L-rhamnosylosy) 
phenylacetonitrile 
C N 
[69] 
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O
OH
O
HO
OH
R1
R2
 
    
Compound name R1  R2 Reference 
Kampferol  
OCH3 
H 
[71] 
Quercetin  
OH OH 
[70] 
 
 
 
 
Chlorogenic acid [71] 
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Ellagic acid [71]  
 
R1
R2
R4
R3  
Compound 
name 
R1 R2 R3 R4 Reference 
Gallic acid 
OH OH OH 
C OH
O
 
[70] 
Ferullic 
acid 
OCH3
 OH H 
c CH C OH
OH
 
[71] 
Vanillin OCH3
 OH H 
C H
O
 
[71] 
Moringyne
  
CH3 
C O Glc
O
 
CH3
 H 
[66] 
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O CH2 CH3
17   
Glycerol-1-(9-octadecanoate) [16] 
  
  β- sitosterol [16] 
 
 
 
 
 
Compound name R Reference 
3-O-(6’-O-oleoyl-β-D-
glucopyranosyl)-β-sitosterol O
CH3
O
H2
C
 
[16] 
β-sitosterol-3-O-β-D-
glucopyranoside 
H2
C
OH 
[16] 
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2.5 Biological activities of Moringa oleifera seeds 
 
Several studies conducted on the seeds of Moringa oleifera plant have shown them to have many 
biological properties.  Firstly Moringa oleifera seeds have exhibited antimicrobial activities 
against various species of microorganisms.  They were found to have in vitro anti-fungal 
activities against Trichophyton rubrum, Trichopyton mentagrophyte, Epidermophyton floccosum 
and Microsprorum canis [
67
].  Jabeen et al.  [
68
] reported strong activity of the crude extract from 
the seeds against Fusariam solani, Bacillus subtilis and Staphlococcus aureus with the following 
minimum inhibitory concentrations (MICs) 24.0 ± 1.50, 22.2 ± 1.15 and 24.0 ± 1.50 
respectively.Moderate activity was observed against Escherichia coli, Aspergillus niger and 
Metarhisium aniscoplae, the MICs were 28.0 ± 1.50, 38.0 ± 0.02 and 32.0 ± 0.9 respectively.  
Similar work by Lar et al.  [
69
] showed antibacterial activity of the seed extract against gram 
negative bacteria (Stigella flexneri and Escherichia coli).  The group concluded that the Moringa 
oleifera seeds can be useful in the treatment of gastrointestinal and wound infections caused by 
gram negative bacteria.  Oluduro et al.  [
70
] also investigated the antimicrobial activity of the 
crude Moringa oleifera seeds extract against E.coli, P. aeruginosa, S. aureus, Cladosporium 
cladosporioides and Penicillium sclerotigenum using a thin layer chromatography bioassay. 
According to their results, 99.2 to 100% inbition against the bacteria was observed. 
Secondly, Moringa oleifera seeds have also exhibited antioxidant property.  This property was 
observed in a study which compared Moringa oleifera seeds oil with palm oil from south east 
Nigeria.  The results showed that both oils have concentration dependent 2,2 diphenyl-1-
picryhydrazy (DDPH) free radical scavenging (antioxidant) activity [
71
].  In their study Sighn et 
al.  [
72
] demonstrated that the seeds extract is able to inhibit the OH
-
-dependent damage of 
polyvinyl chloride deoxyribonucleic acid (PVC) 18 plasmid  DNA. Anticancer activity has also 
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been seen for Moringa oleifera seeds extract.  Four compounds isolated from Moringa oleifera 
seeds namely:{4(α-L-rhamnosyl)-benzyl isothiocyanate; 3-O-(6’-O-oleoyl-β-D-glucopyranosyl)-
β-sitosterol; β-sitosterol-3-O-β-D-glucopyranoside and niazimicin} exhibited in vitro inhibitory 
effects against Epstein-Barr Virus-early antigen (EDV-EA) activation. In vivo testing of 
niazimicin showed its antitumor activity in mouse skin [16].  Moringa oleifera seed oil was 
found to have cytotoxic activity against the following human carcinogenic cells: (breast 
carcinoma cells (MCF-7), colon carcinoma cells (HCT-116), hepatocellular carcinoma cells 
(HEG-2), larynx carcinoma cells (HEP-2) and cervical carcinoma cells (HELA) [
73
].  In addition, 
in vitro studies of the seeds extract, on lung cancer cells (A-549); liver (HEP-2), colon 
(502713HT-29) and neuroblastoma (IMR-32) cancer cells, resulted in percentage inhibition 
varying from 93% for neuriblastoma to 95% for  liver cancer line
72
.  Anti-inflammatory effects 
of the seeds extract were investigated by using experimentally induced acute and sub-acute 
inflammatory models such as (carrageenan induced paw edema method and cotton pellet 
granuloma method).  Investigations, conducted by Fayazuddin et al. [
74
], Caeceres et al. [
75
] and 
Minaiyan et al.  [
76
], found the seeds extract to have concentration dependent anti-inflammatory 
effects , the optimum activity was achieved at 1000 mg kg
-1
. 
 
Different ulcers were induced in rats to test the anti-ulcer activity of the Moringa oleifera seeds.  
Ethanol and pylorus ligation were administered in rats to induce gastric ulcers.  The seeds extract 
was able to prevent the development of those ulcers [
77
].  In another study, rats were 
administered with 20% carbon tetrachloride to induce liver fibrosis.  The rats were then treated 
with the seeds extract and the results showed that the extract was able to reduce liver damage as 
well as the symptoms of liver fibrosis
78
.  The conclusion from the study was that the extract 
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acted against liver injury by a mechanism related to its antioxidant properties and anti-
inflammatory effect [
78
].  Al-Malki and El Rabey  [
79
] studied the antidiabetic effects of the seeds 
powder at low doses.  Diabetic rats that were given a diet supplemented with the seed powder 
recovered to normal renal function, histology of the kidney and pancreas with no pathological 
changes.  The activity was attributed to the antioxidant compounds found in the seeds.  The 
authors suggested that the Moringa oleifera seed powder may have medical benefits if used as a 
food supplement for people with diabetes.  Seed oil of Moringa oleifera has also proven to have 
anthelmintic properties.  The anthelmintic activity is due to the presence of 72% oleic acid in the 
seed oil [85].  This activity was tested by administrating the Pheritima posthuma earthworm 
(which is similar to the worms in the intestines of humans) with the seed oil [
80
].  The death of 
the worms was observed after a short period.  Rathi et al [
81
] reported the wound healing ability 
of Moringa oleifera seeds.  The researchers suggested that the healing ability of the extract may 
be due to the high content of crude protein, zinc and antimicrobial compounds found in the 
seeds. 
 
The ethanol extract from the seeds has exhibited analgesic effects in albino mice.  This is 
supported by study conducted by Dipti S. [
82
].  In the study, he conducted the test using Eddy’s 
Hot plate method.  Mice were given the seeds extract and placed on a hot plate, an increase in 
pain threshold of the mice was observed.  These studies show the importance of Moringa 
oleifera as a medicinal plant.   
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2.6 Separation methods developed for compounds in the other parts of the 
Moringa oleifera plant 
 
Separation methods for quality control have been developed for some of the compounds in the 
different parts of the plant such as the leaves.  Shanker et al. [
83
] developed and validated a 
separation method for niaziridin and niazirin found in the pods and leaves of Moringa oleifera.  
Reference standards used to develop this method were isolated from the plant because they 
cannot be obtained commercially.  The method was validated for linearity, selectivity, precision 
and robustness.  The percentage distributions were 0.015% for niaziridin in the leaves and 
0.038% in the pods and 0.038% and 0.033% for niaziridin in the leaves and pods respectively
83
.  
A separation method for analgesics 1,3-dibenzyl urea and aurantiamide found in the roots of the 
plant was developed.  The method was validated for accuracy, precision, limit of detection and 
limit of quantification [
84
].  Another separation method was developed for antioxidant 
compounds crypton-chlorogenic acid, isoquercetin and astragalin which are found in the leaves 
of Moringa oleifera.  This method was validated for linearity, precision, accuracy, limit of 
detection and limit of quantification.  Applying the method to the crude extract the percentage 
distribution of the compounds in the leaves was found to be 0.081, 0.120 and 0.153% (w/w) for 
crypto-chlorogenic acid, isoquercetin and astragalin respectively
85
.  Reference standards in the 
development of these methods were isolated from the Moringa oleifera plant.  The developed 
and validated methods can be used for quality control for pharmaceutical products of Moringa 
oleifera that contain those compounds 
85
,
86
,
84
. The above-mentioned methods have been 
developed for quantification of those specific compounds and cannot be used for any other 
compound.  However, the method that is being developed in this work will enable the 
simultaneous quantification of all the polar compounds in the extract of the Moringa oleifera 
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seeds.  This is advantageous because it has been reported that compounds in an extract act in 
synergy to give better activity as compared to individual compounds at the same dose [
87
]. 
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CHAPTER THREE 
 
3.  Experimental 
 
This chapter outlines the materials used and the experimental procedures followed for this work.  
The seeds were extracted using the maceration method with a mixture of ethanol and water (1:1, 
v/v) followed by fractionation of the crude extract.  Compounds were then isolated from the 
fractions and their structures were elucidated using spectrometric techniques and confirmed 
using published data.  A separation method for the isolated compounds was developed and 
validated.  The validated method was used to quantify the compounds in the crude extract.  The 
experimental procedures followed in this work are shown in Figure 3.3. 
 
3.1 Reagents and chemicals 
 
All chemical reagents used for this work were of HPLC grade with purity of at least 99%, the 
chemicals for HPLC separation were purchased from Sigma-Aldrich (St Louis, USA) and those 
for extraction were from Merck (Darmstadt, Germany).  All aqueous solutions were prepared 
using ultra-pure water (18.2 mΩ) from a MilliQ water purification system (Molsheim, France).  
The standards for some of the compounds found in the seeds of Moringa oleifera cannot be 
obtained commercially hence they were isolated from the plant. 
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3.2  Sampling and sample treatment 
 
Moringa oleifera seeds were bought from a farm in Chisamba, Zambia.  They were de-coated 
and ground into a fine powder using traditional wood pestle and mortar, Figure 3.1.  The 
powdered seeds were air dried, put in an air tight container and stored at room temperature until 
further use. 
 
Figure 3.1  (a) Moringa oleifera seeds before de-coating (b) seeds after de-coating (c) 
Traditional wood pestle and mortar used for grinding (d)  Grounded seeds (e) 
crude extract from the seeds 
 
3.3  Preparation of the collected seeds for extraction 
 
Two kilograms of dried powdered seeds were macerated in 1 L of ethanol: water (1:1, v/v) 
mixture for 72 hours with constant shaking.  The extract was filtered using a Buchner funnel 
through a Whatman No. 1 filter paper under vacuum, and then concentrated under reduced 
pressure at 60
 
ºC using a rotary evaporator {Figure 3.1 (d)}.  The same batch of seeds was 
extracted three times.  The crude extract was dissolved in 100 mL of ultrapure water and 
a b c d e 
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extracted using 100 mL of petroleum ether, dichloromethane, ethyl acetate or n-butanol 
successively.  Extraction was repeated three times for each solvent.  The resulting fractions were 
concentrated at 60
 
ºC using a rotary evaporator, weighed and put into labelled containers for 
storage at 4 
º
C. 
3.4 Instrumentation  
 
3.4.1  Instrumentation for preparative chromatography 
 
An Ultimate 3000 Dionex preparative HPLC (Dionex softron GmbH, Germering, Germany) with 
an Ultimate 3000 binary pump, diode array detector and a fraction collector was used for 
chromatographic separation and isolation.  The Chromeleon software (version 6.8) was used for 
instrument control and data processing.  The isolated compounds were dried using a free Zone 
2.5 freeze dryer (Labconco, Kansas City, USA).  A photo of the Prep HPLC instrument is shown 
in Figure 3.2 (a). 
 
3.4.2 Instrumentation for structural elucidation 
 
A Vertex series FTIR spectrometer (Bruker optic GmbH, Hamburg, Germany) with a diamond 
ATR fitting was used for analysis. The compounds were analyzed in powder form and the Opus 
7.3.139.1294 software was used to collect the data. The spectra were collected in transmittance 
mode with a resolution of 4 cm
-1
 and were averaged over 32 scans.  An Agilent 500 MHz NMR 
spectrometer (Agilent Technologies, Waldbronn, Germany) using the Vnmrj 4.2 software was 
used for all the NMR spectra.  The compounds were dissolved in dimethyl sulfoxide-d6 to 
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acquire 1D (
1
H and 
13
C) data.  The molecular masses of the compounds were acquired using a 
Bruker Impact II mass spectrometer (Bruker Daltonik GmbH, Bremen, Germany).  The 
compounds were dissolved in a mixture of water and acetonitrile (1:1, v/v) prior to analysis. 
 
3.4.3 Instrumentation for the HPLC separation and quantification method 
 
An HPLC separation and quantification method of the isolated compounds was developed using 
an Agilent HPLC 1260 (Agilent Technologies, Waldbronn, Germany) which consisted of binary 
high pressure pump, autosampler, a thermostat column compartment, a diode array detector and 
a fluorescence detector.  Instrument control, data collection and processing were achieved using 
the Chemstation (version 1.9.0) software.  Chromatographic separation was achieved using 
XTerra C18 columns of different dimensions as specific in the following sections.  A photo of 
this instrument is shown in Figure 3.2 (b). 
 
Figure 3.2  (a) The Ultimate 3000 preparative HPLC (b) The Agilent HPLC 1260 
 
 
a b 
 39 
 
3.5 Experimental procedures 
 
 
 
Figure 3.3  Schematic representation of the procedures  
Grinding of M. oleifera seeds 
Extraction of compounds from the 
seed powder to obtain crude extract 
 
Fractionation of the crude extract 
into fractions of different polarities  
Separation method 
development for up-scaling 
 
 Isolation of compounds from 
the fractions using preparative 
HPLC 
 
Purity check of the isolated 
compounds using TLC and HPLC 
 
Structural elucidation of the isolated 
compounds using NMR, FTIR and 
MS 
Method development for 
separation and quantification 
using HPLC 
 
Validation of the separation and 
quantification method 
Quantification of the isolated 
compounds using the validated 
method 
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3.6  Isolation of the compounds from the different fractions 
 
3.6.1  TLC method development 
 
A TLC method was developed using plates with a silica gel 60 F254 (Merck, Darmstadt, 
Germany).  Two milligrams of each fraction was dissolved in 5 mL of methanol and spotted on a 
marked TLC plate using a capillary tube.  Hexane/chloroform, chloroform/methanol; 
chloroform/methanol/ethyl acetate mixtures at different ratios were tested as the mobile phase. 
 
3.6.2  HPLC analytical method development for up-scaling 
 
Compounds from different fractions obtained in Section 3.3 above were separated on a C18 
XTerra column (50 mm x 4.6 mm, 5 µm) (Waters Corporation, Massachussets, USA) as shown 
in Table 3.1 using an Ultimate 3000 Dionex Preparative HPLC system described above.  Five 
milligrams of each fraction were dissolved in 10 mL of acetonitrile, sonicated and filtered using 
a 0.22 µm PVDF (Sigma-Aldrich, St Louis, USA) syringe filter prior to injecting 10 µL on to the 
analytical column.  Separation was achieved using chromatographic conditions as outlined in 
Table 3.1 and the gradient elution modes given in Table 3.2. 
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Table 3.1  Conditions of the HPLC analytical method for up-scaling 
Column    XTerra C18 (50 mm x 4.6 mm; 5 µm) 
Mobile phase 1% acetic acid (C2H4O2) in ultrapure water (UHP H2O) [A] and 
Acetonitrile (CH3CN) [B] 
Wavelength 254 nm 
Injection volume 10 µL 
Flow rate 1 mL/ min  
Table 3.2  Gradient elution modes for the HPLC separation of the fractions for up-scaling. 1-3 are 
different fractions  
 
1 2 3 
Dichloromethane fraction Ethyl acetate fraction n-butanol fraction 
Time (min) % mobile 
phase A  
Time (min) % mobile 
phase A 
Time (min) % mobile 
phase A 
0 90 0 95 0 95 
3 82 5 88 4 88 
17 68 7 73 6 80 
20 65 9 36 9 65 
24 50 28 28 19 15 
27 36 30 14 24 10 
37 9 35 14   
45 9     
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3.6.3 Isolation of compounds from the fractions using preparative HPLC 
 
The HPLC methods developed on the analytical column as described above were up-scaled to 
preparative HPLC methods for isolation of compounds from the fractions.  An XTerra C18 (150 
mm x 10 mm; 5 µm) preparative column was used for isolation.  The equations below were used 
to calculate the different parameters for the preparative HPLC methods. 
Fprep  = 






analyticalD
prepD
lFanalytica
2
2
 
Where, F prep = Flow rate of the preparative column, F analytical = Flow rate of the analytical 
column, D prep = Inner diameter of the preparative column and D analytical = Inner diameter 
of the analytical column. 
Preparative injection volume = 












lLanalytica
Lprep
analyticalD
prepD
lVanalytica
2
2
 
Where V analytical, D
 
prep and L prep are the analytical injection volume, inner diameter and 
the length of the preparative column respectively, D analytical and L analytical are the inner 
diameter and length of the analytical column respectively.  The calculated parameters are shown 
in Table 3.3. 
The gradient conditions from analytical to preparative methods were calculated in accordance to 
the Waters “Analytical to Prep Gradient Calculator” [88].  The computer gradient elution program 
is shown in Table 3.4; however this program was optimized to shorten the run time as shown in 
Table 3.5.  To prepare the samples for isolation, 2 g of the dichloromethane and ethyl acetate 
fractions were dissolved in 10 mL of acetonitrile: water (1:1 v/v) individually and the n-butanol 
fraction was dissolved in 10 mL water. 
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Table 3.3  Conditions for isolation of compounds from the fractions 
Column  XTerra C18 (150 mm x 10 mm; 5 µm) 
Mobile phase  H2O in 1% acetic acid (A) and CH3CN (B) 
Wavelength  254 nm 
Injection volume 2 mL 
Flow rate  4.7 mL/ min 
 
Table 3.4 Up scaled gradient conditions for the fractions obtained using the Waters calculator 
Dichloromethane Ethyl acetate      n-butanol 
Time (min) % mobile 
phase A  
Time (min) % mobile 
phase A  
Time 
(min) 
% mobile 
phase A  
0 90 0 95 0 95 
9 82 5 88 12 88 
51 68 7 73 18 80 
60 65 9 36 27 65 
72 50 28 28 57 15 
81 36 30 14 72 10 
111 9 35 14   
135 9     
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Table 3.5 Optimized gradient elution modes for preparative isolation of the fractions 
 
n- butanol Dichloromethane and Ethyl acetate 
Time (min) % mobile phase 
A  
Time (min) %  mobile phase A   
0 95 0 90 
15 85 6 80 
21 65 30 60 
30 47 33 55 
 
The system was programmed to collect the fractions as they left the column after separation.  
 
3.6.4  Purity of the isolated compounds 
 
The collected compounds were tested for purity using TLC and the Agilent HPLC 1260 
described in Section 3.4.3.  The mobile phase for TLC was chloroform/methanol at a ratio of 
(60/40); the spots on the plate were visualized using iodine and a UV lamp (Camag, Muttenz, 
Switzerland) at a wavelength of 254 nm. An XTerra C18 column (150 mm X 4.6 mm, 3.5µm) 
was used for separation on the Agilent HPLC 1260 instrument with 1% acetic acid in water and 
acetonitrile at a ratio of (50:50) as the mobile phase under isocratic conditions.  The separated 
compounds were monitored at a wavelength of 254 nm and were checked for percentage peak 
purity using Chemstation software (version 1.9.0).  
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3.7 HPLC method development for separation and quantification of the 
compounds 
 
3.7.1 Separation conditions 
 
Stock solutions were prepared at a concentration of 500 mg L
-1
 using standards obtained from 
the isolation process.  An accurately weighed amount of 2.5 mg using a micro balance (Mettle 
Toledo,Im Langacher Greifensee, Switzerland) of each compound was dissolved in a 5 mL 
volumetric flask and diluted with a mixture of (1:1, v/v) acetonitrile and water.  From the stock 
solutions, a 10 mg L
-1
 artificial mixture was prepared by taking 100 µL from each stock solution, 
diluting and making up to 5 mL with a mixture of (1:1, v/v) acetonitrile and water.  An XTerra 
C18, 150 mm x 4.6 mm, 3.5µm analytical column was used to separate the compounds.  
Acetonitrile and 0.1% formic acid in water were the mobile phase under gradient elution mode.  
The injection volume of 10 µL was used while the separation was monitored at 254 nm.  The 
separation method was optimized by varying the mobile phase composition, solvent flow rate 
from 0.8-1.6 mL min
-1
 and the column temperature (25- 40 
o
C).  The optimum conditions were 
1.4 mL min
-1
 and 40 
o
C for the flow rate and temperature respectively. 
 
3.8. Method validation 
 
The developed method was validated for linearity, limit of detection (LOD), limit of 
quantification (LOQ), precision and specificity. The calibration standard solutions were prepared 
using various isolated standards with purity greater than 90%.  A nine point calibration curve 
was plotted with the standard solutions covering a concentration range of 0.3 to10 mg L
-1
 with 
seven replicates at each concentration level.  
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3.9  Quantification of the compounds in the crude extract 
 
Fifty mg of the crude extract was dissolved in 50 mL of a mixture of acetonitrile and water (1:1, 
v/v), then filtered using a 0.22 µm PVDF syringe filter prior to injecting 10 µL onto a XTerra 
C18 (150 mm x 4.6 mm; 3.5 µm) analytical column.  The prepared sample was analysed using 
the validated method to quantify the isolated compounds in the crude extract.  The calibration 
data was used to calculate the percentage distribution of the isolated compounds in the seeds of 
Moringa oleifera.  
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CHAPTER FOUR 
 
4. Introduction 
 
This chapter presents the results of the work carried out on the extraction, isolation and structural 
elucidation of compounds from Moringa oleifera seeds.  The use of the isolated compounds as 
reference standards in the development and validation of an HPLC separation and quantification 
method of these compounds in the seeds is also reported.  
 
4.1 Extraction of compounds from Moringa seeds 
 
Maceration method was used to extract compounds from the Moringa oleifera seed powder.  A 
mixture of water and ethanol (1:1 v/v) was used as the extraction solvent.  This combination was 
chosen because a mixture of an alcohol and water often results in optimum extraction of 
compounds from a complex matrix.  These solvents are also environmentally friendly and cheap.   
 
Figure 4.1 A histogram showing the different extraction yields from Moringa oleifera seeds. 
275,03 
120,96 
26,76 
0 
50 
100 
150 
200 
250 
300 
Extract 1 Extract 2 Extract 3 
M
as
s 
re
co
ve
re
d
 (
g)
 
Extract number 
 48 
 
The histogram (Figure 4.1) shows the yields of the crude extract for the three subsequent 
extractions. It shows that the extraction yield decreased with subsequent extractions.  Based on 
the low extraction yield after the third extract, it was assumed quantitative extraction had been 
achieved.  The percentage yield for the extraction was 21.15%.  This is significantly higher than 
some extraction yields reported by other researchers.  Chuang P-H et al only managed 6.4% 
extraction yield from Moringa seeds using 70% ethanol [
67
].  In another study, Paliwal R. et al 
achieved a 15.6% yield from the pods of Moringa oleifera using 80% ethanol as the extraction 
solvent [
89
]. 
 
4.2  Liquid-liquid extraction (LLE) 
 
LLE was done in order to fractionate the extract into different polarities that are easier to work 
with when separating the compounds.  Table 4.1 shows the percentage yields for each solvent 
from 400 g of the crude extract.  Dichloromethane extracted most of the compounds followed by 
petroleum ether, ethyl acetate and finally n-butanol.   
 
Table 4.1 Extraction yields from the crude extract using various solvents 
 
Extraction solvent Extraction yield (g) % yield 
Petroleum ether                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      48.9683 12.24
Dichloromethane 53.7426 13.44 
Ethyl acetate 25.8916 6.47 
n-butanol 23.8069 5.95 
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4.3  Isolation of pure compounds from the fractions 
 
The process of isolating compound from the fractions usually starts with the development of a 
separation method using small quantities.  For example to isolate compounds by preparative 
HPLC, a method is first developed using an analytical column which requires small volumes 
then up-scaled to preparative HPLC.  A TLC method can be developed and up scaled to column 
chromatography or Flash Column Chromatography. Using these two approaches is advantageous 
because polar compounds are separated better on the polar stationary phase used in TLC and 
non-polar compounds are separated better on a non-polar stationary phase used in HPLC.  In this 
work we report on TLC and HPLC separation methods that were developed, with the objective to 
upscale them to FCC and preparative HPLC respectively. However, only the up-scaling to 
preparative HPLC for isolation is reported. 
 
4.3.1 TLC Method development 
 
A TLC method was developed because the methods reported in literature are those for extraction 
carried out with different solvents as the ones used in this work. Different mobile phases were 
tested for the separation of the compounds in the fractions.  The compounds had to have 
retardation factors (Rf) between 0.2 and 0.8 for them to be well separated when up scaled to flash 
column chromatography.  Figure 4.2 shows some of the mobile phases that were tested.  When a 
non-polar solvent such as 60/ 40, hexane/chloroform was used, the compounds remained at the 
bottom of the plate and did not move meaning that the compounds had a strong affinity for the 
polar stationary phase {Figure 4.2 (a)}. An attempt with ethyl acetate which is a medium polar 
solvent was then carried out.  Different ratios of the three solvents were tested. The Rf values 
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achieved with 20/70/10 methanol/chloroform/ethyl acetate {Figure 4.2 (d)} ranged from 0.1 to 
0.8 as indicated in Table 4.2. Compounds with smaller Rf values interact more with the polar 
stationary phase. This means that those compounds with smaller Rf values are more polar 
compared to those with higher Rf values. 
 
Figure 4.2 TLC separation of the fractions using different mobile phases (a) 60/40 
hexane/chloroform (b) 50/50 chloroform/methanol (c) 70/30 
chloroform/methanol (d) 20/70/10 methanol/chloroform/ethyl acetate 
 
Table 4.2  Rf values using 20/70/10 methanol/chloroform/ethyl acetate 
 
 
 
 
 
 
 
Petroleum ether 
fraction 
Dichloromethane 
fraction 
Ethyl acetate 
fraction 
n-butanol fraction 
0.1 0.3 0.3 0.2 
0.2 0.7 0.4 0.3 
  0.8 0.5 
   0.6 
   0.7 
a 
b 
c d 
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4.3.2  HPLC separation method development for up-scaling 
 
The HPLC separation method was focused only on the individual fractions of the polar solvents, 
namely dichloromethane, ethyl acetate and n-butanol.  The HPLC separation methods were 
developed to achieve conditions that could be up scaled for the isolation of the compounds using 
preparative HPLC. This approach in isolating compounds from M. oleifera has not been reported 
before. The usual approach starts by isolating the compounds using column chromatography and 
preparative HPLC is used to purify the compounds that could not be purified using column 
chromatography.  Using acetonitrile and water, the compounds in the fractions (dichloromethane, 
ethyl acetate and n-butanol) were initially separated using a 50/50 aqueous/organic mobile phase.  
No separation was observed as the compounds were not retained by the non-polar stationary 
phase, meaning the compounds were very polar.  The polarity of the mobile phase was then 
decreased by increasing the composition of the organic solvent.  This resulted in some of the 
compounds being retained on the stationary phase but still without good separation. Increasing 
acetonitrile content to 70% resulted with two broad peaks for the n-butanol fraction which 
probably suggested co-elution of compounds.  Gradient elution mode was then explored, starting 
with a higher composition of the aqueous solvent and decreasing the composition with an 
increase in time.  The mobile phase and flow rate were optimized and their optimum values 
together with other conditions used are given under the experimental section in Tables 3.1 and 
3.2. 
Figures 4.3-4.5 show typical gradient separations of the compounds in the individual fractions. 
The peaks observed between 0.5 and 1 minute in Figures 4.3-4.5 represent those compounds in 
the fractions that are not retained by the non-polar stationary phase and hence cannot be 
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separated.   In Figure 4.3 about ten peaks were observed probably meaning that there are ten 
compounds in the DCM fraction.  In Figures 4.4 (ethyl acetate fraction) and 4.5 (n-butanol) eight 
and fourteen peaks were observed respectively.  Some of the peaks in the chromatograms were 
showing effects of fronting, tailing and some were broad probably results from compounds being 
retained too long by the stationary phase and the sample being too concentrated.  For this 
intended purpose this was not a problem because the aim at this point was to develop conditions 
for isolation and not for quantification of the compounds. 
 
 
Figure 4.3  A chromatogram of a gradient separation of the dichloromethane fraction using XTerra 
C18 (50 mm x 4.6 mm; 5 µm) under the analytical condition given in Table 3.1 and the 
gradient elution mode in Table 3.2 
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Figure 4.4  A chromatogram of a gradient separation of the ethyl acetate fraction using XTerra C18 
(50 mm x 4.6 mm; 5 µm) under the analytical condition given in Table 3.1 and the 
gradient elution mode in Table 3.2 
 
 
Figure 4.5  A chromatogram of a gradient separation of the butanol fraction using XTerra C18 (50 
mm x 4.6 mm; 5 µm) under the analytical condition given in Table 3.1 and the gradient 
elution mode in Table 3.2 
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Figure 4.6  Schematic representation of the extraction and isolation results 
 
4.3.3 Isolation of compounds using Preparative HPLC 
 
The optimized parameters from the HPLC separation method were up scaled to preparative 
isolation as described in section 3.6.3. The scaled up methods were successful however the run 
times were too long.  Therefore, the gradient conditions were optimized by adjusting the mobile 
phase composition to give shorter run times as shown in Table 3.5 under the experimental 
section.  The method run times were reduced by more than 50% for all the fractions.  Table 3.3 
and Table 3.5 show the parameters and gradient elution modes used for preparative isolation of 
the compounds in the individual fractions. 
Sample 
Crude extract (19.8%) 
Petroleum 
ether 
(12.24%) 
CH2Cl2 
(13.44%) 
C4H802 
(6.47%) 
C
4
H10O 
(5.95%) 
DD DE EI EJ 
BF BG BH BJ BK BM 
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Figure 4.7  Chromatogram for the preparative isolation of compounds from the dichloromethane 
fraction. Using XTerra C18 (150 mm x 10 mm; 5 µm) with the conditions given in Table 
3.3 and the gradient elution mode given in Table 3.5 
 
 
Figure 4.8  Chromatogram for the preparative isolation of compounds from the ethyl acetate fraction.  
Using XTerra C18 (150 mm x 10 mm; 5 µm) with the conditions given in Table 3.3 and 
the gradient elution mode given in Table 3.5 
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Figure 4.9  Chromatogram for the preparative isolation of compounds from the butanol fraction.  
Using XTerra C18 (150 mm x 10 mm; 5 µm) with the conditions given in Table 3.3 and 
the gradient elution mode given in Table 3.5 
The same gradient elution mode (0 min 90% A (H2O), 6 min 80% A, 30 min 60% A, 33 min 
55% A) was used to isolate compounds from two fractions (dichloromethane and ethyl acetate 
fractions).  This is because the two solvents have similar polarity and thus can extract 
compounds that have similar physicochemical properties.  Peaks that were observed on the 
HPLC separation chromatograms could still be seen on the preparative HPLC separation 
chromatograms (Figures 4.3 and 4.4), (Figures 4.7 and 4.8).  This was an indication that the 
HPLC methods were successfully scaled up.  Some of the peaks that can be seen on the HPLC 
chromatogram for the n-butanol fraction (Figure 4.5) are not clearly resolved and were 
overlapping on the preparative HPLC chromatogram (Figure 4.9).  This could be due to 
overloading of the column.  The column was overloaded to increase the recovery of the isolated 
compounds.  
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4.3.4 Determining the purity of the isolated compounds 
 
Once the compounds were isolated, thin layer chromatography (TLC) was used as a quick and 
easy method to assess the purity of the isolated compounds.  Using this technique, a single spot 
on the TLC plate implies that the compound is pure unless there are co-eluting compounds that 
have the same retardation factor thus appearing as one spot.  The compounds that appeared as 
one spot on the TLC plate Figure 4.10 (a) or those that appeared with minor impurities {Figure 
4.10 (b) and (c)} were assessed further for their percentage purity using HPLC.  The 
Chemstation software was used and had a tool to assess the purity of the peak; it also gives a 3D 
image of the peak to check for co-eluting peaks. 
 
Figure 4.10 TLC plates showing the purity of the isolated compounds using 60/ 40 
chloroform/ methanol viewed at a wavelength of 254 nm 
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Figure 4.11   3D pictures of some peaks presenting the isolated compounds using the 
Chemstation software (a) Shows a peak that represents a pure compound 
(b) Shows a peak that represents two compounds that co-elute 
 
The 3D image of the peak enables the viewing of the peak from all angles. As can be seen in 
Figure 4.11 (a) the peak is shown from the side and only one peak can be observed meaning that 
there is no co-elution and the compound is pure. However, in Figure 4.11 (b) shows the presence 
of two co-eluting peaks, where one peak is behind the other.  On a one dimensional 
chromatogram these peaks are observed as one. 
 
Only those compounds whose percentage purity met the set requirement of 90% or more for 
reference standards were characterized.  The accepted compounds had percentage purities in the 
range 90-99% (see Table 4.3). Two compounds each were isolated from the ethyl acetate and 
dichloromethane fractions.  The two compounds from the ethyl acetate fraction were labelled EI 
and EJ; from the dichloromethane fraction were labelled DD and DE. From the n-butanol 
a b 
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fraction, the six compounds isolated were labelled BF, BG, BH, BK, BJ and BM.  These 
compounds are represented by the highlighted peaks in Figures 4.7, 4.8 and 4.9.  Only these 
compounds were further characterized to elucidate their structures.  
The remaining compounds (represented by peaks that are not highlighted on the chromatograms 
Figure 4.7, 4.8, and 4.9) had purity less than 90% and were not purified further because of the 
small quantities that were recovered. This will be focused on in future. 
 
Table 4.3  Percentage purity of the isolated compounds  
 
 
 
 
Compound 
designation 
Retention time on the 
preparative 
chromatogram 
Mass isolated 
from 6 g of the 
fraction 
% Purity 
DD 17.18 (Fig. 4.7) 20 mg 95.4 
DE 19.97 (Fig. 4.7) 18 mg 94.9 
EI 17.14 (Fig. 4.8) 12 mg 97.9 
EJ 20.32 (Fig. 4.8) 30 mg 95.9 
BF 19.25 (Fig. 4.9) 100 mg 91.8 
BG 20.14 (Fig. 4.9) 182 mg 94.3 
BH 22.92 (Fig. 4.9) 136 mg 90.3 
BJ 23.63 (Fig. 4.9) 24 mg 90.5 
BK 24.07 (Fig 4.9) 66 mg 89.7 
BM 26.41 (Fig 4.9) 38 mg 98.9 
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4.4  Characterization of the isolated compounds 
 
4.4.1  Structural elucidation using NMR, FTIR and MS. 
 
The NMR spectra showed that compounds DD, EI, BH, BJ and BK were the same.  Compounds 
DD and EJ were also the same.  The occurrence of the same compound/s in different fractions 
could be due to incomplete extraction of the compound/s by the first solvent and hence they were 
also extracted by subsequent solvents. 
Compound BG was isolated as a white powder {see Figure 4.13 (a)}. The 
13
C NMR spectrum of 
this compound indicated the presence of sixteen carbon atoms (Table 4.4). The 
1
H spectrum 
showed the presence of a tri-substituted aromatic ring. This is indicated by three different peaks 
in the aromatic region δ 6.15, 6.74 and 6.97 which were assigned to C2, C5 and C6. A trans-
substituted ethylene moiety was indicated by peaks at δ5.51 and 7.39. This was supported by 
peaks at δc 115.50 and 146.80 on the 13C spectrum representing olefinic carbons bonded to an 
aromatic ring. The presence of two carbonyl carbons was observed at δc 166.95 and 176.17. This 
is supported by two strong peaks on the FTIR spectrum at 1638.47 and 1685.27 cm
-1
, this similar 
stretch for carbonyl carbon in chlorogenic acid was reported by Prabhu et al.
90
. One of the 
carbons was assigned to an ester group observed at δc 71.52 and is bonded to C5’. The other 
carbonyl carbon was assigned to the carboxylic acid group C7’, the presence of the carboxylic 
acid group is supported by a peak at δ 12.34 on the 1H spectrum. The presence of three carbons 
bonded to hydroxyl groups was observed at δc 69.23, 72.12 and 74.65, this were assigned to C1’, 
C3’and C4’. The methylene groups assigned C2’and C6’ were indicated by peaks at δc 37.40 and 
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38.44..  This data corresponds with literature published by Suarez-Quiroz M.L et al [
91
] and 
Durust N et al [
92
] for the compound 3-caffeoylquinic acid.  Using the mass spectrometer Q-ToF, 
the mass of the compound was found to be 355.1029 m/z [M + H]
 +
 (Appendix), thus confirming 
that the molecular formula of the compound to be  C16H18O9. The structure of the compound is 
shown in Figure 4.12. 
 
DD was isolated as a light yellow solid {see Figure 4.13 (c)}.  Its 
13
C NMR spectrum showed the 
presence of fourteen carbon atoms in the molecule (Table 4.4).  The 
1
H NMR spectrum showed 
the presence of an aromatic ring showing a AA’XX’spin system at δH 7.15 and 6.95.  The double 
peaks were symmetrical meaning that the aromatic ring is para-substituted.  The 
1
H NMR 
spectrum also showed the presence of a sugar moiety indicated by peaks at δ 5.31, 3.78, 3.60, 
3.26 and 3.42 (see Table 4.5).  The presence of three hydroxyl groups on the sugar ring  were 
indicated by peaks at δ 4.85, 4.66 and 5.02 on the 1H NMR spectrum; and was also shown by a 
broad peak on the FTIR spectrum at 3297.37 cm
-1
 (Appendix).  The peak on the sugar moiety 
(1’-H Table 4.5) is shifted downfield and appears at δ 5.31 meaning it is affected by the presence 
of an electronegative atom that is present in its environment.  This is supported by the downfield 
shift of the peak representing one of the carbons on the sugar moiety at δc 98.81.  These results 
corresponds with those of the sugar bonded to the aromatic ring via an α- glycosidic bond (α-L- 
rhamnosyloxy benzyl) [
93
].The aromatic ring is bonded at the anomeric carbon in a trans position 
hence the it is named α rather than β. 
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A peak on 
1H NMR spectrum at δ 9.54 indicates the presence of an NH group; this is supported 
by a strong peak at 1509 cm
-1
 on the FTIR spectrum, representing an NH stretch.  The presence 
of a thiocarbonyl carbon was shown by a peak at δc 190. The double signals at δc 66.61 and 
65.84; 14.74 and 14.53 indicate the presence of an ethoxy group  The molecular mass of the 
compound using a Q-ToF mass spectrometer showed a peak at m/z 358.1406 [M + H]
+
 
(Appendix).  The NMR and MS data for this compound is in agreement with the data published 
by Faizi et al. for the compound O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate, with 
the molecular formula C16H23NO6S [
93
].  This compound was reported to exist as a hybrid at a 
ratio of 2:1, that is indicated by the presence of double signals representing the benzyl ring and 
the ethoxy group; where the NH group can be either cis/trans (DD1 and DD2) to the thiocarbonyl 
group see Figure 4.12 with DD1 being the major form. 
 
Compound BM was isolated as a yellow solid {see Figure 4.13 (d)}.  The NMR data for the 
compound showed that it has the same parent structure as DD (α-L- rhamnosyloxy benzyl), 
however the 
13
C spectrum for BM showed the presence of sixteen carbon atoms which is two 
more than those of O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate.  The molecular mass 
of BM given by mass spectrometry was 386.1720 m/z [M + H]
+
 ( Appendix). The data 
corresponds with that of O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate with the 
molecular formula C18H27NO6S [
94
, 
95
].  This compound, like DD also exists as a hybrid (BM1 
and BM2). O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate has never been reported in 
Moringa oleifera species but Ayyari M. et al [
94
] isolated it from Moringa peregrina species the 
structure is shown in Figure 4.12. O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate and O-
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butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate are reported to have moderate 
antitrypanosomal activity [
94
]. 
 
Compound DE was isolated as a colourless solid {Figure 4.13 (b)}. This compound also has the 
same parent structure as DD which is (α-L-Rhamnosyloxy) benzyl). However the peak 
representing the NH group observed in the other two spectra is missing here. Instead a peak at δc 
129.25 representing the isothiocyanate group is observed. The same chemical shift for an 
isothiocyanate group is reported by Eilert et al. 
96
. This is supported by a medium peak at 2169 
cm
-1
 in the FTIR spectrum which is characteristic of the stretching frequency of  an 
isothiocyanate group.The peak at δc 129.25 ppm represents an isothiocyanate group. The 
presence of the isothiocyanate group is also shown by the strong peak at 2081 cm
-1
 in the FTIR 
spectrum. The molecular mass of the compound was found to be 334.0816 m/z [M + Na]
+
 
(Appendix) corresponding to the molecular formula C14H17SO5N . The NMR data together with 
the mass spectrometry data corresponds to that published by Ragasa et al
60
 and Eilert et al 
96
 for 
the compound 4(α-L-rhamnosyloxy)-benzyl isothiocyanate with the structure shown in Figure 
4.12. 4(α-L-rhamnosyloxy)-benzyl isothiocyanate, O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] 
thiocarbamate  and 3-caffeoylquinic acid are reported to possess antitumor activity [
60
, 
97
]. 
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BG 
 
 
 
X 
       
DD1:  R= -CH2CH3   DD2:  R= -CH2CH3   DE 
BM1:    R = -CH2CH2CH2CH3  BM2:  R= - CH2CH2CH2CH3 
   
Figure 4.12  Structures of the isolated compounds from different fractions of Moringa oleifera seeds 
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Table 4.4  
13C NMR data for the compounds BG in DMSO- d6  at the operational frequency 
of 125 MHz 
 
 
Carbon BG (δ ppm) 
1 126.81 
2 116.00 
3 146.20 
4 149.58 
5 116.96 
6 122.61 
7 146.80 
8 115.50 
9 166.95 
1’ 74.65 
2’ 38.44 
3’ 69.23 
4’ 72.12 
5’ 71.52 
6’ 37.40 
7’ 176.17 
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Table 4.5 13C NMR data for the compounds BG in DMSO- d6  at the operational frequency of 125 MHz 
Carbon  DD (δ ppm) DE (δ ppm) BM (δ ppm) Carbon  DD (δ ppm) DE (δ ppm) BM (δ ppm) 
1 155.61 156.36 155.56 5’ 69.89 69.99 69.86 
 155.58  155.01    69.69 
2,6 116.71 117.13 116.71 6’ 18.35 18.36 18.29 
 116.78    18.36  18.32 
3,5 129.17 128.40 129.18 -OCH2CH3 65.84   
 129.26  129.02  66.61   
4 131.84 129.27 132.11 -OCH2CH3 14.53   
 132.01  131.86  14.74   
7 45.54 47.964 47.56 -OCH2CH2CH2CH3   70.44 
 47.60  45.54 -OCH2CH2CH2CH3   30.76 
8 188.39  190.60    30.56 
 190.45  188.53 -OCH2CH2CH2CH3   19.00 
1’ 98.81 98.72 98.77    18.95 
   98.74 -OCH2CH2CH2CH3   14.06 
2’ 70.65 70.81 70.60    13.96 
3’ 70.85 70.58 70.79     
4’ 72.22 72.16 72.19 
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Table 4.6 1H chemical shifts (ppm) and the coupling constant (Hz) given in brackets for the 
compounds BG in DMSO- d6 at the operational frequency of 500 MHz 
 
Proton BG 
2-H 6.97 dd (1.76, 1.76 ,1.76) 
5-H 6.75 s  
6-H 6.73 s 
7-H 7.42 s 
8-H 5.51 s 
2’-H 1.96 m 
3’-H 6.54 t (7.03) 
4’-H 3.89 s 
5’-H 4.91 d (5.27) 
6’-H 1.75 dd (3.81, 3.81) 
3-OH 9.57 s 
4-OH 9.13 s 
1’-OH 5.04 dd (7.03, 6.44) 
3’-OH 4.09 s 
4’-OH 4.75 d (5.85) 
COOH 12.34 s 
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Table 4.7  1H chemical shifts (ppm) and the coupling constant (Hz) given in brackets for the compounds DD, DE and BM in DMSO- 
d6 at the operational frequency of 500 MHz 
Proton DD DE BM 
2,6-H 6.95 t (1.47) 7.04 tt (2.69, 2.46) 6.95 m 
 6.97 d (3.91)  6.97 dd (3.92, 3.91) 
3,5-H 7.15 dt (3.92, 1.96) 7.29 dd (2.45, 2.45) 7.13 d (8.31) 
 7.20 tt (1.71, 2.20)  7.19 d (8.31) 
7-H 4.21 m 4.82 s 4.20 d (6.36) 
 4.54 m  4.53 d (5.87) 
1’-H 5.31 s 5.36 d (1.47) 5.31 s 
2’-H 3.78 s 3.80 s 3.78 s 
3’-H 3.60 m 3.60 dd (2.93, 2.93) 3.60 t (4.65) 
4’-H 3.26 dd (3.42, 3.42) 3.42 m 3.25 ddd (5.38, 5.38, 5.38) 
5’-H 3.42 dd (3.42, 4.18) 3.26 t (6.20) 3.42 ddt (2.40, 2.03, 4.90) 
6’-H 1.07 m 1.07 d (6.36) 1.07 d (6.36) 
   1.06 d (6.36) 
2’-OH 5.02 s 5.05 s 5.02 d (4.30) 
3’-OH 4.66 m 4.87 s 4.72 d (5.38) 
4’-OH 4.85 d (7.33)  4.85 d (5.38) 
-OCH2CH3 4.37 m   
-OCH2CH3 1.24 ddd (4.40, 4.40, 4.40)   
 1.19 dt (2.54, 3.42)   
-OCH2CH2CH2CH3   4.30 d (6.36) 
   4.33 d(6.36) 
-OCH2CH2CH2CH3   1.56 m 
-OCH2CH2CH2CH3   1.33 tt (7.58. 7.34) 
   1.20 tt (7.34, 7.34) 
-OCH2CH2CH2CH3   0.88 t (7.34) 
-OCH2CH2CH2CH3   0.81 t (7.34) 
-NH 9.54 d (4.89)  9.56 tt (6.11, 6.12) 
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Figure 4.13  (a) BG (b) DE (c) DD (d) BM 
 
4.5  HPLC separation method development for quantification of the isolated 
compounds 
 
The pure isolated compounds were used as reference standards to develop an HPLC separation 
method for their quantification in the Moringa oleifera seeds.  When developing an HPLC 
separation method, certain parameters have to be optimized.  The parameters optimized in this 
study are the mobile phase composition, flow rate and the column temperature.  The starting 
point for method development was with isocratic conditions using 50/50 (0.1% formic acid in 
water and acetonitrile) and a flow rate of 1 mL min
-1
 under ambient temperature (25ºC).  The 
compounds were injected individually to check their retention times under these conditions.  The 
retention times of the compounds were as shown in Table 4.6. 
 
 
 
a b c d 
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Table 4.8 Retention times of the compounds under isocratic condition (50/50), (water/acetonitrile) 
Compound name Retention time (min) 
3-caffeoylquinic acid 3.57 
4(α-L-rhamnosyloxy)-benzyl isothiocyanate 7.36 
O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 11.46 
O-butyl-[4-(α-L-Rhamnosyloxy) benzyl ] thiocarbamate 23.85 
 
The observed retention times show that 3-caffeoylquinic acid was more polar than all the 
compounds and hence had less interaction with the non-polar stationary phase as compared to the 
other compounds.  O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate was the least polar 
because it was retained for a longer period by the non-polar stationary phase than the other 
compounds.  The compounds had different retention times meaning it was possible for them to 
be separated under isocratic conditions.  The next objective was to reduce the analysis run time.  
This was achieved by optimizing each of the following parameters individually: mobile phase 
composition, mobile phase flow rate and the column temperature. 
 
4.5.1 Optimization of the mobile phase composition 
 
Mobile phase composition was the first parameter to be optimized and it was observed that 
increasing the composition of the organic solvent decreased the analysis run time.  A mobile 
phase composition of 60/ 40 (water/ acetonitrile) had a run time of 18 min which was still long 
(chromatogram not shown).  Gradient elution mode was then investigated in order to reduce the 
elution time.  Figures 4.14- 4.18 are chromatograms obtained when using different mobile phase 
{0.1 % formic acid in water (A) and acetonitrile (B)} compositions that were explored. In all the 
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chromatograms: BG= 3-caffeoylquinic acid, DE= 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate, 
DD= O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate and BM= O-butyl-[4-(α-L-
Rhamnosyloxy) benzyl] thiocarbamate. 
 
 
Figure 4.14  Chromatogram for the standard compounds under the following conditions.  Gradient 
elution mode commenced at 0 min 90% (A), 6 min 60% (A), 12 min 50% (A), 14 min 
40% (A), 20 min 10% (A). Flow rate: 1 mL min-1, temperature: 25 ºC. 
 
In Figure 4.14 the run time was still significantly long with the first peak eluted at 9.94 minutes 
and the most retained compound at 15.96 minutes. Increasing the organic solvent content in the 
mobile phase, the gradient elution mode shortened the separation time with the first compound 
eluting earlier, just after 5 minutes. The separation time was reduced from 15 min to about 13 
min (Figure 4.15). 
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Figure 4.15  Chromatogram for the standard compounds under the following conditions. Gradient 
elution mode commencing at 0min 75% A, 3 min 70% (A), 8 min 55% (A), 12 min 
50% (A), 20 min 35% (A). Flow rate: 1 mL min-1, temperature: 25 ºC.  
 
 
Figure 4.16  Chromatogram for the standard compounds under the following conditions. Gradient 
elution mode commencing at 0 min 70% (A), 2 min 65% (A), 5 min 55% (A), 8 min 
45% (A), 10 min 40% (A). Flow rate 1 mL min-1, temperature 25 ºC. 
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Figure 4.17  Chromatogram the standard compounds under the following conditions. Gradient 
elution mode commencing at 0 min 65% (A), 1 min 65% (A), 2 min 55% (A), 3 min 
55% (A), 6 min 45% (A). Flow rate 1 mL min-1, temperature 25 ºC. 
 
Figure 4.18 Chromatogram representing the separation of the compounds under the following 
conditions. Gradient elution mode commencing at 0 min 65% (A), 1 min 55% (A), 3 
min 55% (A). Flow rate 1.4 mL min-1, temperature 40 ºC. 
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The mobile phase composition was optimized further by initially starting with a higher 
percentage of the organic solvent and increasing it over a short period to give the separation 
within 10 minutes (Figure 4.16).  However, the second compound was eluting 4 minutes after the 
first compound indicating that there was still a reasonable window for the later eluting 
compounds to be eluted faster without compromising the resolution.   Further manipulation of 
the mobile phase by increasing the organic content in the mobile phase resulted with shorter 
separation times of less than 6 minutes (Figure 4.17) and 3 minutes (Figure 4.18). Despite the 
fact that the shortest separation time of 3 minutes was favourable and most economical, it was 
noted that when applied to the crude extract, it had limitations since the first eluting compound 
(3-caffeoylquinic acid) was overlapping with interferences thus making it impossible to quantify.  
Therefore the gradient elution mode in Figure 4.18 was used. 
 
4.5.2  Optimization of mobile phase flow rate and column temperature 
 
|Flow rates between 0.7 and 1.6 mL min
-1
 were examined in optimizing the mobile phase flow 
rate.  Generally, an increase in the flow rate resulted in a decrease in the elution time of the 
compounds.  The optimum mobile phase flow rate was taken as 1.4 mL min
-1
.  Temperature as a 
parameter was also investigated at 25, 30, 35 and 40 ºC.  It was observed that an increase in 
temperature resulted in a decrease in the elution time of the compounds.  A temperature of 40 ºC 
was selected as the optimum temperature for the separation of these compounds. Temperatures 
higher than 40 ºC were avoided in fear of the possible degradation of the compounds. A 
chromatogram for the separation of the compounds under the optimized conditions is shown in 
Figure 4.19.  The peaks representing the compounds are well separated and sharp meaning the 
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method is highly selective to separate and quantify the compounds.  The method was then 
applied to the crude extract and it was observed that the compounds were well resolved. 
 
 
Figure 4.19  Chromatogram representing the separation of the compounds under the optimized 
conditions. Gradient elution mode commencing at 0 min 65% (A), 1 min 55% (A), 5 
min 45% (A), flow rate 1.4 mL min-1, temperature 40 ºC  
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4.6 HPLC separation method validation  
 
The method is validated to make sure that it is reproducible so that it can be used by any 
laboratory to quantify the isolated compounds. 
4.6.1 Linearity 
 
An external standard calibration method was used to determine the linearity of the method. 
Linearity is the ability of a method to provide a response that is directly proportional to the 
concentration of the analyte in the sample within a given concentration range [
98
]. Nine 
concentration levels (n = 9) with seven replicates (m = 7) were used.  The number of injections 
per vial (x) was 3 for all the compounds.  The calibration curves were obtained by plotting the 
average peak area versus the concentration of the compounds.  The calibration curves showed 
good linear relationship between the peak area and the concentration in the concentration range 
0.3-10 mg/ L for all the compounds.  The equations of the curves were obtained using the least-
squares method as shown in Table 4.7.  The Table also shows the regression coefficients of the 
compounds were in the range 0.998-0.999, which indicates good linearity. Therefore, the 
calibration curves were used for quantification of the compounds in the crude extract. 
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Table 4.9 Linearity data for the compounds 
Compound name Equation Regression 
coefficient 
(r
2
) 
Standard 
deviation 
(SD) 
Percentage 
relative 
standard 
deviation (% 
RSD) 
3-caffeoylquinic acid y= 3.2065x - 0.2879 0.9990 0.55 x 10
3
 0.056 
4(α-L-rhamnosyloxy)-
benzyl isothiocyanate 
y = 11.324x + 1.551 0.9990 0.87 x 10
3
 0.087 
O-ethyl-[4-(α-L-
Rhamnosyloxy) benzyl] 
thiocarbamate 
y = 1.915x + 0.5136 0.9977 0.73 x 10
3
 0.074 
 O-butyl-[4-(α-L-
Rhamnosyloxy) benzyl ] 
thiocarbamate 
y = 13.49x - 2.373 0.9994 1.7 x 10
3
 0.17 
 
 
4.6.2 Limit of detection (LOD) and Limit of Quantification (LOQ) 
 
LOD is the lowest concentration of the analyte in the sample that can be detected by the 
instrument. LOQ is the lowest concentration of the analyte in the sample that can be quantified 
with accuracy and precision [
99
].  Both LOD and LOQ were determined using the linear 
regression equation according to ISO11843 method, where LOD is based on signal-to-noise ratio 
(S/N) of 3, and LOQ is based on signal-noise-ratio of 10.  
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The following equations were used: 
 
b
S
LOD XY /
3
  and 
b
S
LOQ XY /
10
  
xyS / , is the standard error of regression and b is the slope of the calibration curve.  LODs and 
LOQs for the compounds were ranging from 0.27 to 0.54 mg L
-1
 and from 0.91 to 1.80 mg L
-1
 
respectively (Table 4.8).  These values mean that the compounds can be detected and quantified 
respectively at these levels using this method.  
 
Table 4.10 LOD and LOQ values for all the compounds using the developed method where n= 9 
concentration levels 
 
Compound LOD (mg/L)  LOQ (mg/L)  
3-caffeoylquinic acid 0.35 1.17 
4(α-L-rhamnosyloxy)-benzyl 
isothiocyanate 
0.36 1.18 
O-ethyl-[4-(α-L-
Rhamnosyloxy)benzyl] 
thiocarbamate 
0.54 1.80 
O-butyl-[4-(α-L-
Rhamnosyloxy)benzyl] 
thiocarbamate 
0.27 0.91 
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4.6.3 Precision 
 
Precision measures the ability of a method to give reproducible and repeatable results.  Precision 
is concentration dependent and was therefore measured at low, medium and high concentrations.   
Intra-day variability was assessed using 0.3 mg L
-1
, 3 mg L
-1
 and 10 mg L
-1
 concentrations.  Each 
concentration was injected 10 times from a single vials (three vials for every concentration were 
used).  The results were expressed as percentage relative standard deviation (% RSD).  The % 
RSD (Table 4.9) values for all the compounds were below 2%, which is considered acceptable in 
analytical methodology as it shows that the method is repeatable.  Inter-day variability was 
assessed for 6 consecutive days.  Similar to the intra-day tests, three vials for each concentration 
were injected 10 times on each day.  The % RSD values (Table 4.10) for inter-day variability 
were below 5%, which is considered acceptable and shows that the method is precise. 
 
4.6.4 Specificity  
 
This is the ability of the method to accurately quantify the compound of interest in the presence 
of other compounds [
99
].  Specificity of this method was assessed by comparing the retention 
times of the standards over six days. Their % RSD values were below 5% (Table 4.11).  This 
was also assessed by calculating the percentage difference between the retention times of the 
standards with those of the compounds in the crude extract (see Table 4.12).  
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 The % difference was calculated as follows: 
  % difference = 100
2



sampleRstdR
sampleRstdR
TT
TT  
Table 4.11  Repeatability (Intra-day precision) data, where m= 3 and x= 10 injections for each 
concentration level 
 
 3-caffeoylquinic 
acid 
4(α-L-
rhamnosyloxy)-
benzyl 
isothiocyanate 
O-ethyl-[4-(α-L-
rhamnosyloxy)benzy
l] thiocarbamate 
O-Butyl-[4-(α-L-
rhamnosyloxy) 
benzyl] 
thiocarbamate 
0.3 mg/ L (m=3) 
Mean 
peak 
area 
2.48 6.98 1.18 8.37 
SD 0.03 0.04 0.009 0.45 
% RSD 1.16 0.57 0.77 0.53 
3 mg/L (m= 3) 
Mean 
peak 
area 
24.61 69.45 11.82 84.44 
SD 0.22 0.33 0.099 0.65 
% RSD 0.90 0.48 0.84 0.76 
10 mg/L (m= 3) 
Mean 
peak 
area 
82.45 232.51 39.18 280.56 
SD 0.22 0.28 0.09 0.23 
% RSD 0.27 0.12 0.24 0.08 
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Table 4.12 Intermediate precision data by comparing the peak areas of the standards over six days, where m= 3 and x= 10 injections 
0.3 
mg/L 
BG DE  DD BM 3 
mg/L 
BG DE  DD BM 10 
mg/L 
BG DE  DD BM 
Day 1 2.46 6.95 1.18 8.45 Day 1 24.61 69.45 11.82 84.44 Day 1 82.45 232.51 39.18 280.56 
Day 2 2.47 6.96 1.17 8.52 Day 2 24.46 69.90 11.77 84.63 Day 2 82.83 232.87 39.46 280.58 
Day 3 2.47 6.92 1.18 8.46 Day 3 24.22 69.79 11.75 84.63 Day 3 82.69 232.84 39.74 280.38 
Day 4 2.45 6.94 1.17 8.51 Day 4 24.78 69.76 11.56 84.71 Day 4 82.41 232.76 39.56 280.38 
Day 5 2.44 6.94 1.18 8.48 Day 5 24.71 69.59 11.78 84.69 Day 5 82.42 232.79 39.09 280.71 
Day 6 2.46 6.97 1.17 8.45 Day 6 24.64 69.65 11.79 84.64 Day 6 82.43 232.24 39.56 280.38 
Mean 
(peak 
area) 
2.46 6.95 1.18 8.48 Mean 
(peak 
area) 
24.57 69.69 11.74 84.62 Mean 
(peak 
area) 
82.54 232.67 39.43 280.50 
SD 0.01 0.01 0.002 0.03 SD 0.18 0.14 0.89 0.08 SD 0.16 0.22 0.23 0.13 
%RSD 0.40 0.21 0.19 0.37 %RSD 0.74 0.21 0.75 0.10 %RSD 0.20 0.10 0.58 0.04 
 
BG: 3-caffeoylquinic acid  
DE: 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
DD: O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
BM: O-butyl-4-[(α-L-rhamnosyloxy) benzyl]thiocarbamate 
 82 
 
Table 4.13 Specificity assessment by comparing retention times over six days. n= 1, m=1 and x=10 
injection 
Compound 
name 
Day 1 
RT 
Day 2 
RT 
Day 3 
RT 
Day 4 
RT 
Day 5 
RT 
Day 6 
RT 
Mean SD %RSD 
BG 1.33 1.33 1.33 1.33 1.33 1.33 1.33 0.0008 0.5699 
DE 3.08 3.07 3.06 3.08 3.07 3.06 3.07 0.0058 0.1886 
DD 4.15 4.15 4.14 4.15 4.14 4.14 4.15 0.0038 0.0910 
BM 5.32 5.32 5.32 5.32 5.32 5.32 5.32 0.0025 0.0478 
  
BG: 3-caffeoylquinic acid 
DE: 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
DD: O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
BM: O-butyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
 
Table 4.14  Specificity assessment by comparing percentage difference of the retention times of 
the standard compounds 
Compound name Mean standard Mean sample % difference 
BG 1.33 1.28 3.83 
DE 3.07 3.04 0.98 
DD 4.15 4.13 0.24 
BM 5.32 5.28 0.76 
 
BG: 3-caffeoylquinic acid 
DE: 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
DD: O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
BM: O-butyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
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4.7  Quantification of the compounds in the crude extract 
 
The validated method was applied to the crude extract for quantification of the compounds in the 
extract (Figure 4.20).  The peaks of interest in the sample were identified by comparing their 
retention times with those of the standards.  The unidentified peaks on the chromatogram 
represent the other compounds that are found in the seeds. Identification of these compounds 
required for them to be pure. They were not purified at the current stage because additional steps 
were required for their purification that will be done at a later stage. Quantification results are 
shown in Table 4.13.  It was found that the percentage distribution of the compounds in 50 mg of 
the seeds extract range from 0.25- 1.10%. This means that the remaining unidentified peaks 
represent ± 98% of the compounds in the seeds. 
 
 
Figure 4.20 HPLC separation of the compounds in the crude extract using the validated method 
 
min0.5 1 1.5 2 2.5 3 3.5 4 4.5
mAU
0
5
10
15
20
25
30
 DAD1 A, Sig=250,4 Ref=off (CHOKWE 151215(12) 2015-12-15 20-05-07\062-0202.D)
  Ar
ea:
 38
.89
41
 0.
64
2
 1.
02
3
 1.
16
1
 1.
29
0
 1.
60
0
 2.
51
1
 2.
86
7
 3.
64
9 BM
DDDE
BM
 84 
 
Table 4.15  Percentage distribution of the isolated compounds in 50 mg of the crude extract 
Compound name % ± SD % RSD 
BG 0.190 ± 0.064 1.10 
DE 0.353 ± 0.114 0.27 
DD 1.605 ± 0.800 0.25 
BM 0.027 ± 0.048 3.62 
 
BG: 3-caffeoylquinic acid 
DE: 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
DD: O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
BM: O-butyl-4-[(α-L-rhamnosyloxy) benzyl]thiocarbamate 
 
4.7.1 Spike and identification  
 
To confirm the peaks that were identified in the crude extract represent the compounds of 
interest, the sample was spiked with the 10 mg L
-1
 of the reference standards for the individual 
compounds.  An increase in peak area of the identified peaks was observed {Figures 4.21(a) to 
(d)} which meant that the identified peaks were indeed the peaks of interest. This was also 
confirmed by comparing the UV spectra of the identified peaks to those of the reference 
standards. The chemstation software was used to check for co-elution with interferences and 
there was none for all the peaks of interest. The changes in peak areas are shown in Table 4.14.  
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Table 4.16 Spike and identification data 
Compound name Mean peak area of 
sample 
Mean peak area of 
spiked sample 
Difference (peak 
area) 
BG 5.86 20.06 14.20 
DE 41.64 126.48 84.84 
DD 31.38 41.48 10.10 
BM 1.25 107.775 106.52 
 
BG: 3-caffeoylquinic acid 
DE: 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
DD: O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] thiocarbamate 
BM: O-butyl-4-[(α-L-rhamnosyloxy) benzyl]thiocarbamate 
 
 
Figure 4.21  (a) Sample spiked with 10 mg/L of 3-caffeoylquinic acid (BG) 
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Figure 4.21  (b) Sample spiked with 10 mg/L of 4(α-L-rhamnosyloxy)-benzyl isothiocyanate 
(DE) 
 
Figure 4.21  (c) Sample spiked with 10 mg/L of O-ethyl-4-[(α-L-rhamnosyloxy) benzyl] 
thiocarbamate (DD) 
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Figure 4.21 (d) Sample spiked with 10 mg/L of O-butyl-4-[(α-L-rhamnosyloxy) benzyl] 
thiocarbamate  (BM) 
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CHAPTER FIVE 
Summary, conclusions and future work 
 
5  Introduction 
 
The need for a quality control method for the Moringa products in the market led to this work.  
In this chapter, a summary of the results and conclusions based on the objectives that were set at 
the beginning are given.  This work has been able to address all the set objectives, however 
further work still needs to be done.  Recommendations are thus made with regards to the work 
that needs to be done. 
 
5.1 Summary and conclusions 
 
 Extraction from the seeds of Moringa oleifera  was carried out successfully using the 
maceration method with a mixture of water and ethanol as the extracting solvent.  The 
crude extract was recovered at 21.15%.  The crude extract was further separated into 
fractions of different polarities using petroleum ether, dichloromethane, ethyl acetate and 
n-butanol.  The polar fractions were recovered at a higher percentage yield as compared 
to the non- polar fraction. 
 
 HPLC methods for the separation of the compounds within the fractions were developed.  
These methods were successfully scaled up to preparative HPLC methods which enabled 
quantitative isolation of the compounds from the fractions.  Four compounds of 
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percentage purity between 90 and 99% were isolated.  Preparative HPLC offered the 
advantage of being quick as compared to the traditional column chromatography. 
 
 The compounds were characterized using NMR, FTIR and MS.  The isolated compounds 
were identified as phenolic glucosides; O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] 
thiocarbamate, O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate, 4-(α-L-
Rhamnosyloxy) benzyl isothiocyanate and a polyphenol, 3-caffeoylquinic. O-butyl-[4-(α-
L-Rhamnosyloxy) benzyl] thiocarbamate has not been reported in the Moringa oleifera 
species before but has been reported from Moringa peregrina. 
 
 The isolated compounds were used successfully as reference standards to develop an 
HPLC separation method for their quantification.  A fast separation method of less than 4 
minutes was achieved using an optimum gradient elution programme, flow rate and 
column temperature.  The developed method was validated and showed a linear 
relationship between peak area and concentration of the compounds with regression 
coefficients ranging from 0.998 to 0.999.  The limit of detection and limit of 
quantification for the method were between 0.27 and 0.54 mg/L and 0.91 and 1.80 mg/L 
respectively. The method was found to be precise with %RSD values ranging from 0.53 
to 1.16 at the low concentration, 0.48 to 0.90 at medium concentration and 0.08 to 0.27 at 
high concentration for intraday variability. For inter-day precision the %RSD values were 
ranging from 0.19 to 0.40 at low concentration, 0.10 to 0.73 at medium concentration and 
0.014 to 0.58 at high concentration.  Therefore it can be concluded that the developed 
method is linear, precise and specific to the compounds of interest. 
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 The method was applied to the crude extract to quantify the four identified compounds. 
The percentage compositions of the compounds in 50 mg of the seeds crude extract range 
between 0.25- 1.10% w/w. Therefore this method can be used for the quality control and 
quality assurance of these compounds in Moringa oleifera extracts and products. 
5.2 Further work 
 
It has been reported that compounds or a group of compounds in an extract act in synergy to give 
better activity as compared to an individual compound.  It is therefore necessary to develop a 
method that is able to quantify all the compounds in the extract simultaneously.  For further work 
it is suggested to develop a separation method that is capable of isolating the compounds that 
were not isolated with enough quantities and acceptable percentage purity for their further 
identification.  Upscale the TLC method that was developed to FCC to isolate the compounds 
that can be separated better on a polar stationary phase.  Modify the developed HPLC separation 
method for quantification to include all the compounds found in the Moringa oleifera seeds.  
This will enable the quantification and determination of the percentage distribution of all the 
compounds within the Moringa extracts and products on the market. 
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1
H NMR spectrum of 3-caffeoylquinic acid 
 
13
C NMR spectrum of 3-caffeoylquinic acid 
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FTIR spectrum of 3-caffeoylquinic acid 
 
Mass spectrum of 3-caffeoylquinic acid 
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1
H NMR spectrum of 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate 
 
13
C NMR spectrum of 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate 
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FTIR spectrum of 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate 
 
Mass spectrum of 4-(α-L-Rhamnosyloxy) benzyl isothiocyanate 
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1
H NMR spectrum O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
 
13
C NMR spectrum of O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
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FTIR spectrum of O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
 
Mass spectrum of O-ethyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
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1
H NMR spectrum of O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
 
13
C NMR spectrum of O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
 110 
 
 
FTIR spectrum of O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
 
Mass spectrum of O-butyl-[4-(α-L-Rhamnosyloxy) benzyl] thiocarbamate 
